Analysis of β-agonists by HPLC/ESI-MS(n) in horse doping control.

A sensitive method using LC/ESI-MS(n) has been developed on a quadrupole linear ion trap mass analyser for the detection of nine β(2) agonists (cimaterol, clenbuterol, fenoterol, formoterol, mabuterol, terbutaline, ractopamine, salbutamol and salmeterol) in horse urine. The method consists of solid-phase extraction on CSDAU cartridges before analysis by LC/ESI-MS(n) . The efficiency of extraction combined with the sensitivity and the selectivity of MS(n) allowed the detection of these compounds at pg/mL levels. Administration studies of fenoterol and formoterol are reported and show their possible detection after inhalation. The method is applicable for screening and confirmatory analysis.

[1]  M. Vincenti,et al.  Simultaneous determination of beta2-agonists in human urine by fast-gas chromatography/mass spectrometry: method validation and clinical application. , 2009, Biomedical chromatography : BMC.

[2]  M. Nielen,et al.  Multiresidue analysis of beta-agonists in bovine and porcine urine, feed and hair using liquid chromatography electrospray ionisation tandem mass spectrometry , 2008, Analytical and bioanalytical chemistry.

[3]  G. D. de Erausquin,et al.  Some pharmacodynamic effects of eformoterol in the horse. , 2007, Journal of veterinary pharmacology and therapeutics.

[4]  J. Antignac,et al.  Multi-residue liquid chromatography/tandem mass spectrometric analysis of beta-agonists in urine using molecular imprinted polymers. , 2005, Rapid communications in mass spectrometry : RCM.

[5]  W. E. Woods,et al.  Detection and confirmation of ractopamine and its metabolites in horse urine after Paylean administration. , 2004, Journal of analytical toxicology.

[6]  M. Thevis,et al.  Liquid chromatography/electrospray ionization tandem mass spectrometric screening and confirmation methods for beta2-agonists in human or equine urine. , 2003, Journal of mass spectrometry : JMS.

[7]  J. Tabet,et al.  First mass spectrometric detection of boldenone in horse mane samples , 2003 .

[8]  R. Ventura,et al.  Diagnostic evidence for the presence of beta-agonists using two consecutive derivatization procedures and gas chromatography-mass spectrometric analysis. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[9]  P. Van Eenoo,et al.  Detection of inhaled clenbuterol in horse urine by GC/MS2. , 2002, Biomedical chromatography : BMC.

[10]  K. Deventer,et al.  Quantitative detection of salmeterol after inhalation in equine urine by liquid chromatography/tandem mass spectrometry. , 2002, Rapid communications in mass spectrometry : RCM.

[11]  E. Birks,et al.  Quantification of clenbuterol in equine plasma, urine and tissue by liquid chromatography coupled on-line with quadrupole time-of-flight mass spectrometry. , 2002, Rapid communications in mass spectrometry : RCM.

[12]  R. Ventura,et al.  Validation of qualitative chromatographic methods: strategy in antidoping control laboratories. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[13]  W. E. Woods,et al.  Clenbuterol in the horse: confirmation and quantitation of serum clenbuterol by LC-MS-MS after oral and intratracheal administration. , 2001, Journal of Analytical Toxicology.

[14]  W. E. Woods,et al.  Clenbuterol in the horse: urinary concentrations determined by ELISA and GC/MS after clinical doses. , 2001, Journal of veterinary pharmacology and therapeutics.

[15]  A. Polettini.  Bioanalysis of β2-agonists by hyphenated chromatographic and mass spectrometric techniques , 1996 .

[16]  E. Houghton,et al.  Screening and confirmatory analysis of β-agonists, β-antagonists and their metabolites in horse urine by capillary gas chromatography—mass spectrometry , 1991 .

[17]  J. Zamecnik.  Use of cyclic boronates for GC/MS screening and quantitation of beta-adrenergic blockers and some bronchodilators. , 1990, Journal of analytical toxicology.